Le Lézard

McLaren Health Care, in Partnership With Bunkerhill Health, Launches First-of-its-Kind AI-Powered Cardiovascular Screening in Michigan

McLaren Health Care and its McLaren Heart & Vascular Institute have launched a first-of-its-kind cardiovascular screening program in Michigan to strengthen and expand its ability to identify patients' ...

SEALSQ Announces FY 2025 Key Preliminary / Unaudited Financials Metrics: Reports 66% Year Over Year Revenue Growth to $18 Million

Entered 2026 With a Strong Commercial Momentum Expects Q1 2026 Revenue to Grow over 100% as Compared to Q1 2025Reaffirms FY 2026 Guidance with Revenue Expected to Grow Between 50%-100% Year Over Year ...
Santé log

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

–Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– ...
Frontiers

Modulating Programmed Cell Death: Novel Targets and Novel Molecules

Programmed cell death (PCD) stands at the forefront of innovation in experimental pharmacology and drug discovery, providing fundamental insights into ...